Kocoro (First Place, tie - $15,000)
Kocoro is a digital health platform delivering app-based, remote cardiac rehab to women after cardiac events that addresses a $10.7B market. We support women in their cardiac recovery journey, increasing their access to this life-saving intervention and decreasing healthcare costs.
Kocoro participated in UCLA Anderson Venture Accelerator’s 2022 Summer Activate Cohort.
Enzymetry (First Place, tie - $15,000)
Enzymetry is a technology company that will simplify how clinical trials are activated and conducted by leveraging AI to make transactions and collaborations simpler for the clinical research community.
Enzymetry participated in UCLA Anderson Venture Accelerator’s 2022 Summer Activate Cohort.
NeuroArks (Third Place - $5,000)
NeuroArks's Arc1 aims to provide an effective alternative to traditional treatment options by using transcutaneous electrical stimulation based on peripheral neuromodulation in an effort to alleviate the symptoms and improve outcomes for patients with RLS.
KelpMagic (First Place - $15,000)
KelpMagic is a bioscience startup that provides partners in the $6.7 billion global seaweed economy with high-performance, climate-change resilient kelp varieties. KelpMagic’s bespoke kelps drive growth in the seaweed industry, with varieties built to thrive in warmer and more acidic oceans and optimized for innovative applications in agriculture, pharmaceuticals, bioenergy, bioplastics, and more.
KelpMagic received the Noble Family Innovation Fund.
ThermoShade (Second Place - $10,000)
ThermoShade is a passive cooling panel that can be retrofitted to outdoor structures and create a space that feels up to 20°F cooler than the outside air without any electricity or water. ThermoShade was founded with the mission to make our outdoor spaces more comfortable and safer for people to work, learn, and play, and ultimately to make our cities more resilient to climate change.
Atmos (Third Place - $5,000)
Atmos is a revolutionary integrated carbon credit registry, monitoring, and analytics platform developed to be a foundational support in the global effort to forge a path to a sustainable climate future.
AnonNet – 2021 Healthcare 1st Place
The key insights for improving patient health lie within the vast amount of patient data that medical institutions have collected around the world. This data, though, is protected health information that should rightfully be kept private. To bridge this gap, AnonNet generates synthetic data that artificially mimics the statistical characteristics of raw patient data, providing data holders the opportunity to share the full power of their raw data while under the protection of our government-grade privacy measures. By leveraging state-of-the-art AI at the intersection of deep learning and differential privacy, AnonNet believes synthetic data will unlock new revenue streams in the medical data market, while democratizing it to enable more innovation.
FIG Therapeutics – 2021 Healthcare 2nd Place
FIG Therapeutics develops a biomaterial-based vaccine adjuvant platform that can boost vaccine-induced immune activation and induce long-term immune memory in the body for SARS-CoV-2 and other viruses. This platform uses bioabsorbable submillimeter particles that are scalable for manufacturing, stable for storage, injectable for co-delivery with regular vaccine shots, and adaptable to different vaccine formulations. FIG Therapeutics’ mission is to Foster Immunity Globally by strengthening the efficacy of vaccine candidates, guiding favorable immune responses, and extending immune memories.
SAFR – 2021 Healthcare 3rd Place
SAFR reimagines regional lung dynamics to deliver personalized and precision lung therapy for patients requiring invasive mechanical ventilation to target therapy to regions of the lung and improve patient outcomes.
SAFR participated in 2021 Anderson Venture Accelerator Program.
Bluefin Foods – 2021 Sustainability 1st Place
Bluefin Foods Inc. is a life science technology company that aims to create a better solution to supplying the world with meat food products. We are developing a cost-effective and high-quality process of producing cell-cultured seafood to be a viable substitute for the traditional seafood supply chain.
Bluefin Foods participated in CNSI Magnify incubator and First Look SoCal 2022.
CranioView – 2020 Healthcare 1st Place
CranioView is a medical device company developing a noninvasive imaging platform utilizing machine learning to prevent progression of brain damage in patients with severe neurologic injury.
Nurlabs – 2020 Healthcare 2nd Place
NurLabs is building a novel biophotonics platform for noninvasive cancer diagnostics using saliva, blood, or urine. No reagents, no labels, no sequencing. Low-cost, nondestructive assay with single-molecule accuracy. Clinically validated in gastric and lung cancers.
Used Nurlabs as BCO, CEO participated in Biodesign Fellowship, and Finalist in Global Problem Solvers Innovation Challenge